Truscreen Group (TRU.NZ) Stock Price

Truscreen Group Price

NZX·CLOSED
0.01
​
Market closed

Over the last 9 years Truscreen Group grew revenue by 15.4% annually, reaching 1.71 M NZD. For Truscreen Group, the net margin of -131.0% is up versus -308.1% a few years ago.

Truscreen Group stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Truscreen Group business model & stock analysis

TruScreen Group Ltd. engages in the development, manufacture, and sale of cancer detection device and systems. The firm is engaged in the development of an artificial intelligence (AI)-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. The Company’s cervical screening technology resolves ongoing issues with cytology, including failed samples, poor patient follow-up, patient discomfort, and the need for supporting laboratory infrastructure. The TruScreen device uses opto-electrical technology to evaluate the tissue of the cervix. The TruScreen device consists of a disposable Single Use Sensor (SUS), a Handheld Device (HHD), and an Intelligent Cradle (IC) which works together to detect and identify cancerous and precancerous changes to the cervix. The company also resolves the problems associated with human papillomavirus (HPV) testing, which tests for the much more prevalent HPV virus.

Frequently asked questions about Truscreen Group

Converted at the current exchange rate, the Truscreen Group share trades at 0.01 EUR (0.01 NZD).

The Truscreen Group share (TRU.NZ) is listed on 2 stock exchanges, including: ASX (TRU.AX).

The revenue cannot currently be calculated for Truscreen Group.

The profit cannot currently be calculated for Truscreen Group.

The P/E ratio cannot be calculated for Truscreen Group at the moment.

The P/S cannot be calculated for Truscreen Group currently.

The Eulerpool Quality Score for Truscreen Group is 2/10.

The ISIN of Truscreen Group is NZTRUE0001S7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Truscreen Group is TRU.NZ. The ticker symbol is used to trade Truscreen Group shares on the stock exchange.

Fair ValueTerminal
0.01 NZD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
New Zealand
Currency
NZD
Initial public offering
Nov 12, 2014
ISIN
NZTRUE0001S7
Cusip
Q9225G106
Market capitalization
7.47 M NZDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
7.41
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-169.22 %
Last updated Oct 20, 2026, 8:54 PM

Truscreen Group Peer Group

Truscreen Group Ticker

ASX · TRU.AXNZW · TRU.NZ

Truscreen Group FIGI

TRU:NZ · BBG007HRDYR8TRU:AU · BBG00YJVZPZ4TRU:AT · BBG00YJVZQ00TRU:AH · BBG00YJVZQ46

All fundamentals and in-depth analysis of Truscreen Group

Our stock analysis for Truscreen Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Truscreen Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.